1009119-82-7 Usage
General Description
1,2-Pyrrolidinedicarboxylic acid, 2,2'-[[1,1'-biphenyl]-4,4'-diylbis(2-oxo-2,1-ethanediyl)] bis[1-(1,1-dimethylethyl)] ester, (2S)- is a complex chemical compound with a long name that describes its structure. It is an ester formed from 1,2-pyrrolidinedicarboxylic acid and 2,2'-[[1,1'-biphenyl]-4,4'-diylbis(2-oxo-2,1-ethanediyl)] bis[1-(1,1-dimethylethyl)]. It contains a chiral center with a (2S)- configuration, indicating its stereochemistry. 1,2-Pyrrolidinedicarboxylic acid, 2,2'-[[1,1'-biphenyl]-4,4'-diylbis(2-oxo-2,1-ethanediyl)] bis[1-(1,1-dimethylethyl)] ester, (2S)- may have various pharmaceutical or industrial applications, as esters can be used in drug formulation, as flavorings, or as solvents, among other uses.
Check Digit Verification of cas no
The CAS Registry Mumber 1009119-82-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,9,1,1 and 9 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1009119-82:
(9*1)+(8*0)+(7*0)+(6*9)+(5*1)+(4*1)+(3*9)+(2*8)+(1*2)=117
117 % 10 = 7
So 1009119-82-7 is a valid CAS Registry Number.
1009119-82-7Relevant articles and documents
MICRO-ELECTROLYSIS REACTOR FOR ULTRA FAST, OXIDANT FREE, C-C COUPLING REACTION AND SYNTHESIS OF DACLATASVIR ANALOGS THEREOF
-
, (2020/12/01)
The present invention relates to a continuous micro-electro-flow reactor system for ultra-fast, oxidant free, C—C coupling reaction for making symmetrical biaryls and analogs thereof. This invention further relates to the said process for preparation of antiviral drug, daclatasvir of general formula I.
PROCESS FOR THE PREPARATION OF DACLATASVIR DIHYDROCHLORIDE AND ITS INTERMEDIATES
-
Paragraph 0037; 0039, (2018/10/04)
The present invention relates to an improved process for the preparation of Daclatasvir dihydrochloride by using compound salt of formula (VIIc).
Preparation method of daclatasvir and its intermediate
-
Paragraph 0043; 0061; 0067; 0068; 0069, (2017/08/28)
The invention discloses a preparation method of daclatasvir and its intermediate. The invention provides a preparation method of a daclatasvir intermediate I. The method includes the step of: in an organic solvent or under a solvent-free condition, subjec